These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 20437036

  • 1. Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.
    Crépin S, Laroche ML, Sarry B, Merle L.
    Eur J Clin Pharmacol; 2010 Jun; 66(6):547-54. PubMed ID: 20437036
    [Abstract] [Full Text] [Related]

  • 2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 3. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Udvardy E, Redl P, Márton I.
    Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.
    Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS, Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators.
    J Oral Maxillofac Surg; 2010 Feb; 68(2):243-53. PubMed ID: 19772941
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G.
    Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
    [Abstract] [Full Text] [Related]

  • 6. Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
    Jackson GH, Morgan GJ, Davies FE, Wu P, Gregory WM, Bell SE, Szubert AJ, Navarro Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross FM, Byrne J, Roddie H, Rudin C, Boyd KD, Osborne WL, Cook G, Child JA.
    Br J Haematol; 2014 Jul; 166(1):109-17. PubMed ID: 24673708
    [Abstract] [Full Text] [Related]

  • 7. [Jaw osteonecrosis induced by oral biphosphonates: 12 cases].
    Barrier A, Lescaille G, Rigolet A, Descroix V, Goudot P, Ruhin B.
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):196-202. PubMed ID: 20810140
    [Abstract] [Full Text] [Related]

  • 8. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
    Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum S, Pautke C.
    J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
    [Abstract] [Full Text] [Related]

  • 9. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

  • 10. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Sánchez A, Blanco R.
    Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
    [Abstract] [Full Text] [Related]

  • 11. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Al Mardini M, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, St-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Canadian Association of Oral and Maxillofacial Surgeons.
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [Abstract] [Full Text] [Related]

  • 12. Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
    La Verde N, Bareggi C, Garassino M, Borgonovo K, Sburlati P, Pedretti D, Bianchi C, Perrone S, Mihali D, Cobelli S, Mantica C, Rizzo A, Farina G.
    Support Care Cancer; 2008 Nov; 16(11):1311-5. PubMed ID: 18663482
    [Abstract] [Full Text] [Related]

  • 13. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.
    Narongroeknawin P, Danila MI, Humphreys LG, Barasch A, Curtis JR.
    Spec Care Dentist; 2010 Mar; 30(2):77-82. PubMed ID: 20415805
    [Abstract] [Full Text] [Related]

  • 15. Bisphosphonate associated osteonecrosis of the jaw.
    Khan AA, Sándor GK, Dore E, Morrison AD, Alsahli M, Amin F, Peters E, Hanley DA, Chaudry SR, Lentle B, Dempster DW, Glorieux FH, Neville AJ, Talwar RM, Clokie CM, Mardini MA, Paul T, Khosla S, Josse RG, Sutherland S, Lam DK, Carmichael RP, Blanas N, Kendler D, Petak S, Ste-Marie LG, Brown J, Evans AW, Rios L, Compston JE, Canadian Taskforce on Osteonecrosis of the Jaw.
    J Rheumatol; 2009 Mar; 36(3):478-90. PubMed ID: 19286860
    [Abstract] [Full Text] [Related]

  • 16. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
    Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM.
    Oncologist; 2008 Aug; 13(8):911-20. PubMed ID: 18695259
    [Abstract] [Full Text] [Related]

  • 17. [Bisphosphonates and osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882
    [Abstract] [Full Text] [Related]

  • 18. Spontaneous Healing of Clodronate-Related Osteonecrosis of the Jaw.
    Nastro Siniscalchi E, Allegra A, De Ponte FS, Oteri G, Cervino G, Lauritano F, Musolino C, Cicciù M.
    J Craniofac Surg; 2017 Oct; 28(7):e687-e689. PubMed ID: 28857991
    [Abstract] [Full Text] [Related]

  • 19. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC.
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [Abstract] [Full Text] [Related]

  • 20. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
    Montazeri AH, Erskine JG, McQuaker IG.
    Eur J Haematol; 2007 Jul; 79(1):69-71. PubMed ID: 17598839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.